Daniel Mazzolenis is currently Director Clinical Development, Oncology/Hematology in the LatAm Business Unit of INC Research, based in Buenos Aires Argentina, working on many practical aspects of conducting Clinical Research in Latin America.
As a hematologist his main area of work was clinical hemostasis and antithrombotic treatment. He joined the Pharmaceutical Industry in 1995, where he was Medical Director for Otsuka Pharmaceuticals and Sanofi Synthelabo, Product Manager for Hemophilia at Novonordisk, and General Manager at a Regional Latin American CRO.
He is an MD from the Univeridad Nacional de La Plata, and completed residencies in Internal Medicine and Hematology, a Specialist degree in Pharmacology at the Universidad de Buenos Aires and an MBA at the Universidad del CEMA, and courses on Pharmacoeconomics, Business Strategy, etc.
He was President of SAMEFA, the Argentine Pharmaceutical Physicians Society, and member of the organizing Committees of LACCR of 2008, 2009 and 2011.
His main areas of interest are Clinical Research, Biologics and Thrombosis & Hemostasis.